Recent Company News

• 08:03 AM ET Apr 28, 2025
  

  Evaxion Biotech announces EVX-01 data to be presented at AACR ($1.65, 0.00)

• 08:00 AM ET Apr 10, 2025
  

  Evaxion to present at World Vaccine Congress

• 07:34 AM ET Apr 01, 2025
  

  Evaxion Biotech reports FY EPS ($0.20) vs year-ago ($0.81) ($1.85, 0.00)

• 07:30 AM ET Apr 01, 2025
  

  Evaxion announces business update and full year 2024 financial results

• 08:00 AM ET Mar 27, 2025
  

  Evaxion to announce business update and full year 2024 financial results on April 1, 2025

• 04:32 PM ET Mar 25, 2025
  

  Evaxion Biotech to present new phase 2 data for AI-designed personalized cancer vaccine EVX-01 at AACR Annual Meeting ($1.75, 0.00)

• 04:04 PM ET Mar 13, 2025
  

  Evaxion Biotech files $50M ordinary shares shelf - F-3 ($1.79, 0.00)

• 08:00 AM ET Mar 04, 2025
  

  Evaxion to present at numerous upcoming conferences

• 08:05 AM ET Feb 25, 2025
  

  Evaxion extends phase 2 trial with personalized cancer vaccine EVX-01 to further enhance clinical data package ($2.44, 0.00)

• 05:59 PM ET Feb 03, 2025
  

  StreetAccount Summary - After-hours trading update